US Broker Ratings

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Titan with Limited Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, is a noteworthy player in the diagnostics and research industry. With a market capitalization of $37.49 billion, the company..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 65% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors in the biotechnology sector with its promising drug development pipeline and impressive market cap of $14.35 billion. As a..

Quest Diagnostics (DGX) Investor Outlook: Analyzing Potential Upside Amidst Robust Revenue Growth

For investors navigating the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing opportunity, bolstered by its substantial market capitalization of $20.27 billion. With its headquarters in Secaucus, New..

Veeva Systems Inc. (VEEV) Stock Analysis: A Strong Buy with 9.42% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) is a prominent player in the healthcare sector, specifically within the health information services industry. As a leading provider of cloud-based solutions tailored for the..

The Cigna Group (CI) Stock Analysis: Exploring a 21.45% Upside Potential in the Healthcare Sector

The Cigna Group (NYSE: CI) has emerged as a compelling option for investors seeking a robust presence in the healthcare sector. With a market capitalization of $80.55 billion, Cigna operates..

Waters Corporation (WAT) Stock Analysis: Navigating a Healthcare Giant with Strong Revenue Growth and Robust Analyst Support

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment narrative with its robust revenue growth and high analyst interest...

Stryker Corporation (SYK) Stock Analysis: 12.46% Potential Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, stands at the forefront of the medical device industry. With a market capitalization of $145.96 billion, this U.S.-based company is..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating Growth with a 19.88% Return on Equity

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector specifically within diagnostics and research, continues to draw investor attention with its robust performance metrics and strategic market..

Bristol-Myers Squibb (BMY) Stock Analysis: A 21% Potential Upside in Healthcare Investment

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, offers intriguing opportunities for investors with its current market position and potential upside. With a market cap of $89.21..

Intuitive Surgical, Inc. (ISRG): Investor Outlook with an 8.74% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG) continues to capture investor attention with its innovative contributions to the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Investor Outlook Highlights 25.45% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology industry, presents a compelling opportunity for investors, boasting a potential upside of 25.45% according to analyst ratings. With a..

Elevance Health, Inc. (ELV) Stock Analysis: A Stable Player with 13.52% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, offers a robust investment case with a compelling potential upside of 13.52%. This healthcare behemoth, headquartered in..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a Potential Upside of 11.94% Amid Strong Buy Ratings

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $38.46 billion, this Ohio-based company..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking a $402 Billion Giant with Strong Market Position

AbbVie Inc. (ABBV), a major player in the healthcare sector, stands out with a formidable market capitalization of $402.76 billion, making it one of the giants in the drug manufacturing..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating a 16.40% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, commands a market cap of $218.53 billion and holds a prominent position in the drug manufacturing industry. With..

Astrazeneca PLC (AZN) Stock Analysis: Riding the 11.75% Potential Upside Wave

AstraZeneca PLC (AZN), a towering presence in the biopharmaceutical sector, continues to capture investor attention with its promising growth trajectory and robust pipeline of prescription medicines. With a market capitalization..

Novo Nordisk A/S (NVO) Investor Outlook: Can This Danish Pharma Giant Deliver a 14% Upside?

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has been a formidable player in the global pharmaceutical industry for nearly a century. With its headquarters nestled in..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating the 12% Upside Potential for Investors

Investors in the healthcare sector often look for stable, growth-oriented companies that can withstand market volatility while delivering consistent returns. Becton, Dickinson and Company (NYSE: BDX) stands as a compelling..

Gilead Sciences, Inc. (GILD): Investor Outlook with a Solid 2.61% Dividend Yield and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) continues to stand as a formidable player in the biopharmaceutical industry, with a robust market capitalization of $150.06 billion. As a leading name in the..

Boston Scientific Corporation (BSX) Stock Analysis: Impressive 24.75% Potential Upside Captures Investor Attention

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, offers a compelling narrative for investors seeking robust growth potential. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds